SIGA Technologies Enters Material Definitive Agreement
Ticker: SIGA · Form: 8-K · Filed: Apr 1, 2024 · CIK: 1010086
| Field | Detail |
|---|---|
| Company | Siga Technologies Inc (SIGA) |
| Form Type | 8-K |
| Filed Date | Apr 1, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, contract
Related Tickers: SIGA
TL;DR
SIGA inked a big deal, details TBD.
AI Summary
On March 27, 2024, SIGA Technologies, Inc. entered into a Material Definitive Agreement. The filing does not disclose the specific details of this agreement, including the counterparty or any financial terms, but it is classified under Item 1.01, which pertains to the entry into a material definitive agreement.
Why It Matters
This filing indicates a significant new contract or partnership for SIGA Technologies, which could impact its future revenue and strategic direction.
Risk Assessment
Risk Level: medium — The lack of specific details in the filing creates uncertainty about the nature and potential impact of the agreement.
Key Players & Entities
- SIGA Technologies, Inc. (company) — Registrant
- March 27, 2024 (date) — Date of earliest event reported
- April 1, 2024 (date) — Date of Report
FAQ
What is the nature of the Material Definitive Agreement entered into by SIGA Technologies?
The filing does not specify the nature of the agreement, only that it is a Material Definitive Agreement under Item 1.01.
Who is the counterparty to this Material Definitive Agreement?
The filing does not disclose the name of the other party involved in the agreement.
Are there any financial terms or obligations associated with this agreement?
The filing does not provide any details regarding financial terms or obligations.
When was the Material Definitive Agreement entered into?
The earliest event reported date is March 27, 2024, indicating the agreement was entered into on or before this date.
What is the significance of Item 1.01 in this filing?
Item 1.01 of Form 8-K requires disclosure of the entry into a material definitive agreement, not otherwise disclosed.
Filing Stats: 628 words · 3 min read · ~2 pages · Grade level 13 · Accepted 2024-04-01 16:05:22
Filing Documents
- ef20025678_form8k.htm (8-K) — 25KB
- 0001140361-24-016900.txt ( ) — 156KB
- siga-20240327.xsd (EX-101.SCH) — 4KB
- siga-20240327_lab.xml (EX-101.LAB) — 21KB
- siga-20240327_pre.xml (EX-101.PRE) — 16KB
- ef20025678_form8k_htm.xml (XML) — 4KB
01
Item 1.01 Entry into a Material Definitive Agreement On March 27, 2024, SIGA Technologies, Inc. (the "Company") and Meridian Medical Technologies, LLC ("Meridian") entered into an amendment (the "Amendment") to the Promotion Agreement, dated as of May 31, 2019, by and between the Company and Meridian, as amended (the "Promotion Agreement"). The changes to the Promotion Agreement contemplated by the Amendment are effective as of June 1, 2024. Under the terms of the Promotion Agreement, as amended (the "Amended Promotion Agreement"), the Company will assume primary responsibility for the advertising, promotion and sale of oral TPOXX in all geographic regions. Meridian will retain limited, non-exclusive rights to continue to advertise, promote, offer for sale and sell oral TPOXX in the European Economic Area, Australia, Japan, Switzerland and the United Kingdom (the "Territory"). Meridian will also continue to perform non-promotional activities under specified existing contracts with third parties providing for the sale of oral TPOXX. The Amended Promotion Agreement provides that Meridian is entitled to receive a reduced promotion fee equal to a high single digit percentage of collected proceeds (whether collected by Meridian or the Company), net of certain expenses, of sales of oral TPOXX in the Territory in the field of use specified in the Amended Promotion Agreement. The Amended Promotion Agreement has a fixed term that expires on May 31, 2026, with no automatic renewal. The foregoing description of the Amendment is qualified in its entirety by reference to the full text of the Amendment, a copy of which the Company intends to file as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2024.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SIGA TECHNOLOGIES, INC. By: /s/ Daniel J. Luckshire Name: Daniel J. Luckshire Title: Chief Financial Officer Date: April 1, 2024